Clinical Scorecard: The Dual Role of Estrogen in Kidney Disease: Balancing Protective and Detrimental Effects Through Precision Modulation

At a Glance

Key Highlights

• Estrogen has protective effects in CKD through various signaling pathways.
• Sexual dimorphism influences the progression of CKD, with women generally experiencing slower decline in renal function.
• Estrogen's dual role can promote disease progression under certain pathological conditions.
• Fluctuations in estrogen levels correlate with CKD incidence, particularly in perimenopausal women.
• Precision modulation of estrogen signaling may offer therapeutic potential in kidney disease management.

Guideline-Based Recommendations

Diagnosis

• Monitor renal function markers such as blood urea nitrogen and creatinine in relation to estrogen levels.

Management

• Consider targeting estrogen receptor signaling pathways for potential renoprotective benefits.

Monitoring & Follow-up

• Evaluate estrogen exposure duration in women as a risk factor for CKD.

Risks

• Elevated estrogen levels may exacerbate kidney disease under certain conditions, such as pregnancy or autoimmune disorders.

Patient & Prescribing Data

Women, particularly those in perimenopausal and postmenopausal stages.

Estrogen exposure duration is negatively correlated with CKD onset.

Clinical Best Practices

• Integrate sex-based precision medicine approaches in CKD management.
• Conduct further research to elucidate estrogen's complex mechanisms in kidney disease.

Related Resources & Content

• Global Burden of Disease Study 2023
• Estrogen and Kidney Disease Mechanisms